Mernissi G E, Doucet A
Am J Physiol. 1984 Sep;247(3 Pt 2):F485-90. doi: 10.1152/ajprenal.1984.247.3.F485.
To test whether sodium availability controls the concentration of renal Na-K-ATPase, we evaluated the effect of chronic alterations in apical membrane sodium permeability in specific nephron segments on the maximal activity of Na-K-ATPase. For this purpose Na-K-ATPase activity was determined in nephron segments microdissected from rats treated continuously for 3-8 days with either furosemide or amiloride, two diuretics known to lower the apical permeability to sodium in the thick ascending limb and the collecting tubule, respectively. Unexpectedly, Na-K-ATPase activity was decreased neither in the thick ascending limb nor in the collecting tubule after administration of either drug. In fact, both diuretics paradoxically increased the pump activity by 60-150% in the collecting tubule. This stimulation of Na-K-ATPase activity was accompanied with an enhancement of the collecting tubule diameter. Stimulation of Na-K-ATPase was identical in the collecting tubule of diuretic-treated rats receiving spironolactone. These results suggest that Na-K-ATPase maximal activity is not controlled by sodium availability or by aldosterone under these conditions and that chronic administration of furosemide or amiloride induces Na-K-ATPase activity in the collecting tubule. This effect appears to be independent of aldosterone.
为了检测钠的可利用性是否控制肾钠钾ATP酶的浓度,我们评估了特定肾单位节段顶端膜钠通透性的慢性改变对钠钾ATP酶最大活性的影响。为此,在从用速尿或氨氯吡咪连续处理3 - 8天的大鼠中显微分离出的肾单位节段中测定钠钾ATP酶活性,这两种利尿剂分别已知可降低髓袢升支粗段和集合管对钠的顶端通透性。出乎意料的是,给予任何一种药物后,髓袢升支粗段和集合管中的钠钾ATP酶活性均未降低。事实上,两种利尿剂都反常地使集合管中的泵活性增加了60 - 150%。钠钾ATP酶活性的这种刺激伴随着集合管直径的增大。在接受螺内酯的利尿剂处理大鼠的集合管中,钠钾ATP酶的刺激作用是相同的。这些结果表明,在这些条件下,钠钾ATP酶的最大活性不受钠的可利用性或醛固酮的控制,并且速尿或氨氯吡咪的长期给药可诱导集合管中的钠钾ATP酶活性。这种作用似乎与醛固酮无关。